Cocrystal Pharma Inc

Research Cocrystal Pharma Inc (COCP) on Bullrun: market cap USD 14.20M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCOCP
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 14.20M
• Financial periodFY2025
• Net income-USD 8.83M
• Free cash flow-USD 8.20M

Valuation Snapshot

latest market cap is USD 14.20M.

About Cocrystal Pharma Inc

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hepatitis C virus (HCV) infections.

Frequently asked questions

What is Cocrystal Pharma Inc's market cap?

Cocrystal Pharma Inc's market capitalization is USD 14.20M.

What does Cocrystal Pharma Inc do?

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States.